Pendapatan dodolan perusahaan invizyne.com (EXOZ)
eXoZymes Inc develops cell-free platforms for biofuel synthesis protected by molecular patents, while the integration of its biocatalysts into industry standards ensures stable demand. The company's sales volume trajectory reflects a trend where the indicator value reaches 0.00. High barriers to entry in bioengineering and stringent environmental regulations make the leadership position in green chemistry virtually unattainable.
%20Pendapatan%20lan%20volume%20dodolan&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_EXOZ_-_eXoZymes-Inc_-_Revenue-and-Sales-Volume "EXOZ: Total pendapatan perusahaan Invizyne 13.02.2025 - 14.11.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan eXoZymes (EXOZ)
- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- informasi babagan utang lan solvabilitas:
Utang marang Modal eXoZymes Inc|EXOZ - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas eXoZymes Inc|EXOZ - Gunggung utang perusahaan|Utang-utang marang nilai buku Invizyne Technologies, Inc.|EXOZ - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan eXoZymes|Likuiditas darurat invizyne.com
- data bathi bisnis lan rasio investasi:
EXOZ - Bathi resik perusahaan|Prakiraan bathi perusahaan eXoZymes Inc|EXOZ - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi eXoZymes|EXOZ - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Invizyne Technologies, Inc.|EXOZ - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajrone 12 wulan pungkasan eXoZymes|EXOZ - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan invizyne.com|EXOZ - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep eXoZymes Inc
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:EXOZ (invizyne.com)
Daily revenue volume establishes the mathematical basis for separating a sustainable trend from market noise. This metric captures phase transitions of the economic cycle through the analysis of multiple compression. For eXoZymes Inc (EXOZ), this flow reflects the commercial efficiency of implementing innovative enzymes developed by a multidisciplinary team of chemists and biologists. Investors must assess the risk of capital freeze by analyzing the company's trading revenue dynamics.
Analisis perusahaan pesaing
HLN: Pendapatan dodolan perusahaan|Pendapatan perusahaan Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Jyong Biotech MENS|Ligand Pharma - Pendapatan perusahaan|AMRX - Pendapatan perusahaan|Total pendapatan perusahaan perrigo.com|ALVO (Alvotech SA) - Dodolan perusahaan|Total volume dodolan perusahaan Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Pendapatan lan volume dodolan|ANIP: Pendapatan dodolan perusahaan|Pendapatan perusahaan Afrezza (MNKD)|Pendapatan lan volume dodolan amphastar.com (AMPH)|Pendapatan lan volume dodolan PCRX (pacira.com)|Pendapatan dodolan perusahaan SPRY|Theravance Biopharma Inc - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Aquestive Therapeutics AQST|SCPH: Pendapatan lan volume dodolan|Dodolan perusahaan Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Pendapatan lan volume dodolan|SXTC (China SXT Pharmaceuticals, Inc.) - Total dodolan perusahaan|Pendapatan perusahaan eupraxiapharma.com (EPRX)|Total dodolan perusahaan BHST|Pendapatan perusahaan Oramed Pharmaceuticals ORMP|Pendapatan dodolan perusahaan ENTX|HYFT - Pendapatan perusahaan|Pendapatan dodolan perusahaan ABVC (ABVC BioPharma Inc.)|CPIX: Pendapatan lan volume dodolan|Quantum BioPharma Limited - Pendapatan dodolan perusahaan|FGEN (FibroGen Corp) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Telomir Pharmaceuticals|Pendapatan lan volume dodolan RANI|SNYR (Synergy CHC Corp.) - Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan RLYB (Rallybio Corp)|LEXX: Volume dodolan perusahaan|PULM - Pendapatan perusahaan|PTHL: Pendapatan perusahaan|APM (aptorumgroup.com) - Dodolan perusahaan|Lyra Therapeutics - Pendapatan dodolan perusahaan|Pendapatan perusahaan Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Pendapatan reged perusahaan|Pendapatan lan volume dodolan YCBD|PRFX: Pendapatan tahunan perusahaan|Pendapatan perusahaan altamiratherapeutics.com CYTO|Pendapatan lan volume dodolan Lipella Pharmaceuticals Inc LIPO|OPTN - Pendapatan perusahaan|Pendapatan reged perusahaan Pieris Pharma PIRS|Procaps Group SA (PROC) - Pendapatan perusahaan|Pendapatan tahunan perusahaan PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Pendapatan lan volume dodolan|SLRN: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan TFFP
